Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer—21-yr Follow-up
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in European Urology Focus
- Vol. 8 (1) , 134-140
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-upNew England Journal of Medicine, 2018
- Which technology to select for primary focal treatment of prostate cancer?—European Section of Urotechnology (ESUT) position statementProstate Cancer and Prostatic Diseases, 2018
- Follow-up of Prostatectomy versus Observation for Early Prostate CancerNew England Journal of Medicine, 2017
- High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A ReviewJournal of Endourology, 2017
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate CancerEuropean Urology, 2017
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016JAMA Oncology, 2017
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerNew England Journal of Medicine, 2016
- Whole-gland Ablation of Localized Prostate Cancer with High-intensity Focused Ultrasound: Oncologic Outcomes and Morbidity in 1002 PatientsEuropean Urology, 2014
- Evolution and Outcomes of 3 MHz High Intensity Focused Ultrasound Therapy for Localized Prostate Cancer During 15 YearsJournal of Urology, 2013
- Fourteen‐year oncological and functional outcomes of high‐intensity focused ultrasound in localized prostate cancerBJU International, 2013